TIAA CREF INVESTMENT MANAGEMENT LLC - ANTHERA PHARMACEUTICALS INC ownership

ANTHERA PHARMACEUTICALS INC's ticker is ANTH and the CUSIP is 03674U201. A total of 73 filers reported holding ANTHERA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.31 and the average weighting 0.0%.

Quarter-by-quarter ownership
TIAA CREF INVESTMENT MANAGEMENT LLC ownership history of ANTHERA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$54,000
-34.1%
126,3800.0%0.00%
Q4 2016$82,000
-80.2%
126,380
-4.1%
0.00%
Q3 2016$415,000
-36.7%
131,730
-38.0%
0.00%
-100.0%
Q2 2016$656,000
-13.2%
212,457
+1.8%
0.00%0.0%
Q1 2016$756,000
-22.6%
208,710
-0.9%
0.00%0.0%
Q4 2015$977,000
-23.9%
210,6000.0%0.00%0.0%
Q3 2015$1,283,000
-20.6%
210,600
+12.4%
0.00%0.0%
Q2 2015$1,615,000187,3180.00%
Other shareholders
ANTHERA PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Abingworth LLP 861,723$1,174,0000.98%
R&F Capital Advisors LP 171,205$111,0000.04%
Rhenman & Partners Asset Management AB 200,000$130,0000.02%
Rock Springs Capital Management LP 380,000$247,0000.02%
WHITE PINE CAPITAL LLC 35,000$23,0000.01%
BVF INC/IL 62,292$40,0000.01%
Virtu KCG Holdings LLC 271,239$176,0000.00%
TURNER INVESTMENTS LLC 15,000$10,0000.00%
TWO SIGMA SECURITIES, LLC 11,736$8,0000.00%
Tower Research Capital LLC (TRC) 36,413$24,0000.00%
View complete list of ANTHERA PHARMACEUTICALS INC shareholders